Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LANADELUMAB-FLYO Cause Hereditary angioedema? 794 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 794 reports of Hereditary angioedema have been filed in association with LANADELUMAB-FLYO. This represents 53.2% of all adverse event reports for LANADELUMAB-FLYO.

794
Reports of Hereditary angioedema with LANADELUMAB-FLYO
53.2%
of all LANADELUMAB-FLYO reports
13
Deaths
311
Hospitalizations

How Dangerous Is Hereditary angioedema From LANADELUMAB-FLYO?

Of the 794 reports, 13 (1.6%) resulted in death, 311 (39.2%) required hospitalization, and 44 (5.5%) were considered life-threatening.

Is Hereditary angioedema Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LANADELUMAB-FLYO. However, 794 reports have been filed with the FAERS database.

What Other Side Effects Does LANADELUMAB-FLYO Cause?

Product dose omission issue (177) Inappropriate schedule of product administration (144) Drug ineffective (137) Headache (126) Weight decreased (125) Weight increased (120) Injection site pain (119) Product use issue (114) Malaise (90) Nausea (77)

What Other Drugs Cause Hereditary angioedema?

HUMAN C1-ESTERASE INHIBITOR (5,572) ICATIBANT (2,221) LANADELUMAB (1,343) ECALLANTIDE (519) BEROTRALSTAT (124) CINRYZE (119) OMALIZUMAB (59) HUMAN IMMUNOGLOBULIN G (47) KALBITOR (45) BERINERT (30)

Which LANADELUMAB-FLYO Alternatives Have Lower Hereditary angioedema Risk?

LANADELUMAB-FLYO vs LANREOTIDE LANADELUMAB-FLYO vs LANSOPRAZOLE LANADELUMAB-FLYO vs LANTHANUM LANADELUMAB-FLYO vs LANTUS LANADELUMAB-FLYO vs LANTUS SOLOSTAR

Related Pages

LANADELUMAB-FLYO Full Profile All Hereditary angioedema Reports All Drugs Causing Hereditary angioedema LANADELUMAB-FLYO Demographics